Department of Pharmacology Archives
Vanderbilt, Ono Pharmaceutical extend drug discovery agreement
May. 25, 2017—Vanderbilt University Medical Center (VUMC), Vanderbilt University and Japan-based Ono Pharmaceutical Co. Ltd. have expanded a drug discovery agreement initiated in 2015 that will now run through 2019.
Discovery Lecturer Kandel tackles age-related memory loss
May. 11, 2017—Eric Kandel, M.D., who was awarded the Nobel Prize in 2000 for discovering molecular mechanisms of memory storage, told the crowd at last week’s Flexner Discovery Lecture that he has recently become interested in memory in the aging brain.
Barnett named co-chair of VUSM Admissions Committee
Apr. 27, 2017—Joey Barnett, Ph.D., has been named co-chair of the Vanderbilt University School of Medicine Admissions Committee, effective July 1.
Nobel laureate and memory expert Kandel set for next Discovery Lecture
Apr. 27, 2017—Nobel laureate Eric R. Kandel, M.D., renowned for his studies of learning and memory, will give the next Flexner Discovery Lecture on Thursday, May 4.
Graduate student’s research lauded by P.E.O. Sisterhood
Apr. 20, 2017—Nicole Perry, a graduate student in Pharmacology at Vanderbilt University School of Medicine, is one of 100 doctoral students in the United States and Canada selected to receive a $15,000 P.E.O. Scholar Award this year from the P.E.O. Sisterhood, a philanthropic educational organization based in Des Moines, Iowa.
Emerging Scholar
Mar. 23, 2017—Rene Raphemot, Ph.D., a National Institutes of Health postdoctoral fellow at Duke University, delivered the inaugural Discovery Science Emerging Scholars Lecture at Vanderbilt University School of Medicine last week.
Melanoma study finds new way to enhance targeted therapies
Mar. 9, 2017—With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.
Lindsley’s drug discovery efforts land ASPET Award
Jan. 12, 2017—Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Research that ruled in 2016: Readers’ favorite stories
Dec. 16, 2016—Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.
Investigators explore new way to control mosquitoes
Dec. 1, 2016—In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth.
Reducing antidepressants’ side effects
Nov. 23, 2016—Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.
Brown named interim director of Institute of Chemical Biology
Nov. 3, 2016—H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
